Axa S.A. Global Blood Therapeutics, Inc. Transaction History

Axa S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $1.59 Million - $2.7 Million	-42,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $2.06 Million - $3.46 Million	42,300 New	42,300 $2.67 Million
Q3 2018 Nov 08, 2018	SELL	$38.0 - $51.1 $193,800 - $260,610	-5,100 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$38.7 - $50.15 $762,390 - $987,955	-19,700 Reduced 79.44%	5,100 $231,000
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $982,080 - $1.63 Million	24,800 New	24,800 $1.2 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.